Skip to contentO
Organon & Co.
O
OGNOrganon & Co. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.59B$1.59Bderived−0.4% vs Q4 2023 Net Income$109.00M$109.00Mderived−80.0% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$896,000,000— Operating Cash Flowderived$390,000,000−1.8% Free Cash Flowderived$335,000,000+5.3% Margins · derivedGross margin56.3%
Net margin6.8%−27.3 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 28, 2025 · 59 d after period end